Top compounds associated with response to DEDD2


Feature Type Standardized
Nominal ANOVA
mRNA Doxorubicin gCSI pan-cancer AAC -0.14 0.01
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.093 0.01
mRNA WZ8040 CTRPv2 pan-cancer AAC 0.1 0.01
mRNA Repligen 136 CTRPv2 pan-cancer AAC 0.097 0.01
mRNA Panobinostat CCLE pan-cancer AAC 0.11 0.01
mRNA neratinib CTRPv2 pan-cancer AAC 0.093 0.01
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.095 0.01
mRNA tacedinaline CTRPv2 pan-cancer AAC 0.098 0.01
mRNA BRD-K86535717 CTRPv2 pan-cancer AAC 0.18 0.01
mRNA Talazoparib GDSC1000 pan-cancer AAC -0.083 0.01
Download CSV